| Cat. No. |
Product Name / Activity |
| 3914 |
A 419259 trihydrochloride |
| Inhibitor of Src family kinases |
| 3963 |
AZM 475271 |
| Src tyrosine kinase inhibitor |
| 4361 |
Bosutinib |
| Dual Src-Abl inhibitor; antiproliferative |
| 6793 |
Dasatinib |
| Highly potent pan-Src/Bcr-Abl inhibitor |
| 6976 |
JNJ 10198409 |
| c-Abl, Lck, c-Src and Fyn kinase inhibitor; also inhibits PDGFRα and PDGFRβ |
| 4660 |
KB SRC 4 |
| Potent and selective c-Src inhibitor |
| 5592 |
LCB 03-0110 dihydrochloride |
| Potent c-SRC kinase inhibitor; also inhibits DDR2, BTK and Syk |
| 3063 |
1-Naphthyl PP1 |
| Src family kinase inhibitor; also inhibits c-Abl |
| 3785 |
PD 166285 dihydrochloride |
| Potent Src inhibitor; also inhibits FGFR1, PDGFRβ and Wee1 |
| 1397 |
PP 1 |
| Potent, selective Src family kinase inhibitor |
| 1407 |
PP 2 |
| Potent, selective Src family kinase inhibitor |
| 2794 |
PP 3 |
| Negative control for PP 2 (Cat. No. 1407) |
| 7189 |
Saracatinib |
| Potent and selective Src tyrosine kinase family inhibitor; anticancer; antiviral; orally bioavailable |
| 3642 |
Src I1 |
| Dual site Src kinase inhibitor |
| 6475 |
SU 6656 |
| Potent ATP-competitive Src family kinase inhibitor; also AMPK inhibitor; cell permeable |
| 3567 |
TC-S 7003 |
| Potent Lck inhibitor |
| 5579 |
Tilfrinib |
| Potent and selective breast tumor kinase (Brk) inhibitor |
| 6981 |
TL 0259 |
| Selective and highly potent Fgr and Lyn kinase inhibitor; orally bioavailable |
| 5413 |
WH-4-023 |
| Potent and selective Lck and Src inhibitor; also inhibits SIK |